Treatment of systemic lupus erythematosus with mycophenolate mofetil
Open Access
- 1 March 2001
- journal article
- review article
- Published by SAGE Publications in Lupus
- Vol. 10 (3) , 203-208
- https://doi.org/10.1191/096120301673517315
Abstract
Mycophenolate mofetil is an immunosuppressive drug that is of established efficacy in renal transplantation. It inhibits the de novo pathway of purine synthesis and therefore lymphocyte proliferati...Keywords
This publication has 41 references indexed in Scilit:
- Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidneyKidney International, 2000
- Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in ratsKidney International, 1999
- Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletionNephrology Dialysis Transplantation, 1999
- Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamideAmerican Journal of Kidney Diseases, 1998
- Effect of mycophenolic acid on TNFα‐induced expression of cell adhesion molecules in human venous endothelial cells in vitroBritish Journal of Pharmacology, 1997
- REDUCED HUMAN IgG ANTI-ATGAM ANTIBODY FORMATION IN RENAL TRANSPLANT RECIPIENTS RECEIVING MYCOPHENOLATE MOFETIL1,2Transplantation, 1995
- MYCOPHENOLIC ACID, AN INHIBITOR OF IMP DEHYDROGENASE THAT IS ALSO AN IMMUNOSUPPRESSIVE AGENT, SUPPRESSES THE CYTOKINE-INDUCED NITRIC OXIDE PRODUCTION IN MOUSE AND RAT VASCULAR ENDOTHELIAL CELLSTransplantation, 1995
- Human Type I and II IMP Dehydrogenases as Drug TargetsAnnals of the New York Academy of Sciences, 1993
- Therapy of Lupus NephritisNew England Journal of Medicine, 1986
- IMMUNOLOGICAL OBSERVATIONS ON PATENTS WITH LESCH-NYHAN SYNDROME, AND ON THE ROLE OF DE-NOVO PURINE SYNTHESIS IN LYMPHOCYTE TRANSFORMATIONThe Lancet, 1975